OTCMKTSMKTS:NUGN

NuGene International Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume84,476 shs
Market Capitalization$190,000.00
P/E RatioN/A
Dividend YieldN/A
Beta7.55

Competitors

NuGene International (OTCMKTSMKTS:NUGN) Vs. EL, CL, NTCO, COTY, IPAR, and EPC

Should you be buying NUGN stock or one of its competitors? Companies in the industry of "toilet preparations" are considered alternatives and competitors to NuGene International, including The Estée Lauder Companies (EL), Colgate-Palmolive (CL), Natura &Co (NTCO), Coty (COTY), Inter Parfums (IPAR), and Edgewell Personal Care (EPC).

The Estée Lauder Companies (NYSE:EL) and NuGene International (OTCMKTSMKTS:NUGN) are both consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

Insider & Institutional Ownership

55.0% of The Estée Lauder Companies shares are owned by institutional investors. 14.0% of The Estée Lauder Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares The Estée Lauder Companies and NuGene International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
The Estée Lauder Companies4.38%32.72%7.91%
NuGene InternationalN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for The Estée Lauder Companies and NuGene International, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
The Estée Lauder Companies041502.79
NuGene International0000N/A

The Estée Lauder Companies presently has a consensus price target of $285.9524, indicating a potential downside of 8.43%.

Volatility and Risk

The Estée Lauder Companies has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500. Comparatively, NuGene International has a beta of 7.55, suggesting that its stock price is 655% more volatile than the S&P 500.

Earnings and Valuation

This table compares The Estée Lauder Companies and NuGene International's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Estée Lauder Companies$14.29 billion7.93$684 million$4.1275.80
NuGene InternationalN/AN/AN/AN/AN/A

The Estée Lauder Companies has higher revenue and earnings than NuGene International.

Summary

The Estée Lauder Companies beats NuGene International on 7 of the 8 factors compared between the two stocks.

NuGene International (OTCMKTSMKTS:NUGN) and Colgate-Palmolive (NYSE:CL) are both consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.

Volatility and Risk

NuGene International has a beta of 7.55, meaning that its share price is 655% more volatile than the S&P 500. Comparatively, Colgate-Palmolive has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500.

Profitability

This table compares NuGene International and Colgate-Palmolive's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NuGene InternationalN/AN/AN/A
Colgate-Palmolive16.65%383.88%17.10%

Insider and Institutional Ownership

76.5% of Colgate-Palmolive shares are owned by institutional investors. 0.8% of Colgate-Palmolive shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings for NuGene International and Colgate-Palmolive, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
NuGene International0000N/A
Colgate-Palmolive27202.00

Colgate-Palmolive has a consensus target price of $82.1667, suggesting a potential upside of 1.82%.

Valuation & Earnings

This table compares NuGene International and Colgate-Palmolive's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NuGene InternationalN/AN/AN/AN/AN/A
Colgate-Palmolive$15.69 billion4.36$2.37 billion$2.8328.52

Colgate-Palmolive has higher revenue and earnings than NuGene International.

Summary

Colgate-Palmolive beats NuGene International on 7 of the 8 factors compared between the two stocks.

NuGene International (OTCMKTSMKTS:NUGN) and Natura &Co (NYSE:NTCO) are both consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, profitability, risk and valuation.

Earnings and Valuation

This table compares NuGene International and Natura &Co's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NuGene InternationalN/AN/AN/AN/AN/A
Natura &Co$3.66 billion3.37$39.40 million$0.09199.44

Natura &Co has higher revenue and earnings than NuGene International.

Institutional and Insider Ownership

4.8% of Natura &Co shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current recommendations for NuGene International and Natura &Co, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
NuGene International0000N/A
Natura &Co10001.00

Profitability

This table compares NuGene International and Natura &Co's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NuGene InternationalN/AN/AN/A
Natura &CoN/AN/AN/A

Summary

Natura &Co beats NuGene International on 2 of the 2 factors compared between the two stocks.

Coty (NYSE:COTY) and NuGene International (OTCMKTSMKTS:NUGN) are both consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Profitability

This table compares Coty and NuGene International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Coty-15.56%-3.35%-0.72%
NuGene InternationalN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Coty and NuGene International, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Coty18502.29
NuGene International0000N/A

Coty presently has a consensus target price of $6.6875, indicating a potential downside of 25.69%.

Volatility and Risk

Coty has a beta of 2.25, indicating that its stock price is 125% more volatile than the S&P 500. Comparatively, NuGene International has a beta of 7.55, indicating that its stock price is 655% more volatile than the S&P 500.

Insider & Institutional Ownership

22.7% of Coty shares are owned by institutional investors. 1.9% of Coty shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Coty and NuGene International's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Coty$4.72 billion1.46$-1,006,700,000.00($0.48)-18.75
NuGene InternationalN/AN/AN/AN/AN/A

NuGene International has lower revenue, but higher earnings than Coty.

Inter Parfums (NASDAQ:IPAR) and NuGene International (OTCMKTSMKTS:NUGN) are both consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, profitability and risk.

Valuation and Earnings

This table compares Inter Parfums and NuGene International's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inter Parfums$713.51 million3.19$60.25 million$1.9037.82
NuGene InternationalN/AN/AN/AN/AN/A

Inter Parfums has higher revenue and earnings than NuGene International.

Profitability

This table compares Inter Parfums and NuGene International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Inter Parfums5.94%5.12%3.98%
NuGene InternationalN/AN/AN/A

Insider & Institutional Ownership

53.1% of Inter Parfums shares are held by institutional investors. 44.7% of Inter Parfums shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Volatility & Risk

Inter Parfums has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Comparatively, NuGene International has a beta of 7.55, meaning that its share price is 655% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and price targets for Inter Parfums and NuGene International, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Inter Parfums05102.17
NuGene International0000N/A

Inter Parfums presently has a consensus price target of $62.50, suggesting a potential downside of 13.03%.

Summary

Inter Parfums beats NuGene International on 7 of the 8 factors compared between the two stocks.

Edgewell Personal Care (NYSE:EPC) and NuGene International (OTCMKTSMKTS:NUGN) are both consumer staples companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, profitability and analyst recommendations.

Institutional & Insider Ownership

92.3% of Edgewell Personal Care shares are owned by institutional investors. 1.0% of Edgewell Personal Care shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Edgewell Personal Care and NuGene International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Edgewell Personal Care3.47%10.83%4.37%
NuGene InternationalN/AN/AN/A

Volatility & Risk

Edgewell Personal Care has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500. Comparatively, NuGene International has a beta of 7.55, suggesting that its share price is 655% more volatile than the S&P 500.

Valuation & Earnings

This table compares Edgewell Personal Care and NuGene International's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edgewell Personal Care$1.95 billion1.08$67.60 million$2.7314.19
NuGene InternationalN/AN/AN/AN/AN/A

Edgewell Personal Care has higher revenue and earnings than NuGene International.

Analyst Recommendations

This is a breakdown of current recommendations for Edgewell Personal Care and NuGene International, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Edgewell Personal Care13102.00
NuGene International0000N/A

Edgewell Personal Care currently has a consensus price target of $35.20, suggesting a potential downside of 9.14%.

Summary

Edgewell Personal Care beats NuGene International on 7 of the 8 factors compared between the two stocks.


NuGene International Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
The Estée Lauder Companies logo
EL
The Estée Lauder Companies
2.1$312.29flat$113.29 billion$14.29 billion190.42Analyst Report
Decrease in Short Interest
Analyst Revision
Colgate-Palmolive logo
CL
Colgate-Palmolive
2.2$80.70flat$68.40 billion$15.69 billion25.78Analyst Report
Natura &Co logo
NTCO
Natura &Co
0.1$17.95flat$12.35 billion$3.66 billion199.44High Trading Volume
Coty logo
COTY
Coty
1.2$9.00flat$6.90 billion$4.72 billion-7.76News Coverage
Inter Parfums logo
IPAR
Inter Parfums
1.6$71.86flat$2.27 billion$713.51 million71.86
Edgewell Personal Care logo
EPC
Edgewell Personal Care
1.8$38.74flat$2.10 billion$1.95 billion31.24
e.l.f. Beauty logo
ELF
e.l.f. Beauty
1.3$29.90flat$1.53 billion$282.85 million157.38Analyst Report
Insider Selling
Analyst Revision
News Coverage
Mandom logo
MDOMF
Mandom
0.5$24.55flat$1.19 billion$752.29 million27.28
Revlon logo
REV
Revlon
0.9$10.96flat$576.50 million$2.42 billion-1.63News Coverage
UG
United-Guardian
1.0$15.31flat$70.27 million$13.60 million17.01Increase in Short Interest
ETFM
FOMO
0.5$0.01flat$42.50 millionN/A0.00
GDSI
Global Digital Solutions
0.0N/AN/A$39.91 millionN/A0.00News Coverage
CCA Industries logo
CAWW
CCA Industries
1.0$2.21flat$16.79 million$17.14 million-110.50
DS Healthcare Group logo
DSKX
DS Healthcare Group
0.5$0.00flat$60,000.00N/A0.00
ASCBQ
Ascendia Brands
0.2$0.00flat$0.00N/A0.00
EROX
Human Pheromone Sciences
0.0N/AN/A$0.00N/A0.00
LPHM
Lee Pharmaceuticals
0.2N/AN/A$0.00N/A0.00
NXRA
Nextera Enterprises
0.0$0.00flat$0.00N/A0.00
SPCO
The Stephan
0.2N/AN/A$0.00N/A0.00
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.